LUCID DIAGNOSTICS INC's ticker is and the CUSIP is 54948X109. A total of 23 filers reported holding LUCID DIAGNOSTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $154,310 | -22.6% | 131,871 | -8.1% | 0.00% | – |
Q2 2023 | $199,416 | +242.9% | 143,465 | +245.3% | 0.00% | – |
Q1 2023 | $58,160 | +103757.1% | 41,543 | 0.0% | 0.00% | – |
Q4 2022 | $56 | -99.9% | 41,543 | +6.2% | 0.00% | – |
Q3 2022 | $59,000 | -26.2% | 39,116 | +10.3% | 0.00% | – |
Q2 2022 | $80,000 | -72.0% | 35,476 | -58.4% | 0.00% | – |
Q1 2022 | $286,000 | +17.7% | 85,277 | +88.2% | 0.00% | – |
Q4 2021 | $243,000 | – | 45,304 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LUMINUS MANAGEMENT LLC | 825,000 | $1,122,000 | 0.28% |
Nantahala Capital Management | 279,537 | $380,170 | 0.02% |
LEVIN CAPITAL STRATEGIES, L.P. | 36,799 | $50,047 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 135,000 | $183,600 | 0.01% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 133,000 | $180,880 | 0.00% |
Geneos Wealth Management Inc. | 33,850 | $46,036 | 0.00% |
Arcus Capital Partners, LLC | 3,100 | $4,216 | 0.00% |
Verition Fund Management LLC | 36,166 | $49,186 | 0.00% |
UBS Group AG | 3,565 | $4,848 | 0.00% |
VANGUARD GROUP INC | 319,433 | $434,429 | 0.00% |